Home
    • Plans Blog Contact
    Shoulder Innovations, Inc. logo

    Shoulder Innovations, Inc.

    SI
    Last price US$20.73
    Market cap US$647.2m
    12M price change 50.65%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    Beta Bionics, Inc.BBNX Industry peer Carlsmed, Inc.CARL Industry peer Heartflow, Inc.HTFL Industry peer Propanc Biopharma, Inc.PPCB Sector peer
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    Shoulder Innovations, Inc. Overview

    Industry: Medical/Dental Instruments

    Sector: Health Care

    Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations' ecosystem, which is designed to improve core components of shoulder surgical care - preoperative planning, implant design and procedural efficiency - to benefit each stakeholder in the care chain. Shoulder Innovations' ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care. Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations' ecosystem, which is de Read More

    Newly listed company coverage

    Verified company profile, price history, and SEC registration source are available.

    Review the SEC registration filing

    Mavefund brings filings, fundamentals, valuation, price history and news for Shoulder Innovations, Inc. into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed Aug 06, 2026

    Quarterly result summary

    Revenue was $17.2M (reported). Net loss was -$10.2M (-47% YoY). Adjusted EBITDA was -$8M (-56% YoY).

    Revenue $17.2M reported
    Net loss -$10.2M -47% YoY
    Adjusted EBITDA -$8M -56% YoY

    What changed

    • Revenue reported to $17.2M.
    • Net loss -47% YoY to -$10.2M.
    • Adjusted EBITDA -56% YoY to -$8M.

    Guidance / outlook

    No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

    Earnings release Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing 10-Q Aug 06, 2026 SEC filing 8-K Aug 06, 2026 SEC filing 10-Q May 13, 2026 SEC filing 8-K May 13, 2026 Earnings release Earnings release May 13, 2026 SEC filing 10-K Mar 10, 2026 SEC filing 8-K Mar 10, 2026 Earnings release Earnings release Mar 10, 2026 SEC filing 8-K Nov 12, 2025 SEC filing 10-Q Nov 12, 2025 Earnings release Earnings release Nov 12, 2025

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    Earnings Per Share

    Score 0.00/5
    Shoulder Innovations, Inc. earns a low score, as its Earnings Per Share (EPS) has not shown continuous growth over the last six years. Notable counterparts in the sector with high scores includes Propanc Biopharma, Inc. Aktis Oncology, Inc.
    In Medical/Dental Instruments industry , Beta Bionics, Inc. , Carlsmed, Inc. , Heartflow, Inc. are companies with high ratings.

    Return on Equity

    Score 3.00/5
    Shoulder Innovations, Inc. stands out with a superior score in the Return on Equity (ROE) section, surpassing the sector median value and showcasing its strong performance in this metric. The top companies in the same sector include Propanc Biopharma, Inc. Aktis Oncology, Inc.
    Shoulder Inn... SI US$647.2m
    Propanc Biop... PPCB US$26.7m
    Aktis Oncolo... AKTS US$1.5b

    Net Margin

    Score 5.00/5
    Shoulder Innovations, Inc. commands a high score, propelled by its net margin consistently outpacing the sector median value and exhibiting continuous growth in recent six years; noteworthy counterparts in the sector, boasting similarly high scores, include Propanc Biopharma, Inc. Aktis Oncology, Inc.
    Shoulder Inn... SI US$647.2m
    Propanc Biop... PPCB US$26.7m
    Aktis Oncolo... AKTS US$1.5b

    Share Buyback

    In Medical/Dental Instruments industry , Beta Bionics, Inc. , Carlsmed, Inc. , Heartflow, Inc. are companies with high ratings.

    Leverage

    Score 5.00/5
    Shoulder Innovations, Inc. attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as Propanc Biopharma, Inc. Aktis Oncology, Inc. , also exhibit high scores.
    Shoulder Inn... SI US$647.2m
    Propanc Biop... PPCB US$26.7m
    Aktis Oncolo... AKTS US$1.5b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Reported currency
    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    Shoulder Innovations, Inc. logo

    Shoulder Innovations, Inc.

    US$20.73

    US$647.2m

    0.68%

    50.65%